Nano Dimension’s Chairman & CEO Responds to the Latest 16-03-2023, 03:47

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer 7-04-2024, 19:46

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00